264 results on '"Weekers, Laurent"'
Search Results
2. The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation
3. Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?
4. Efficacy of Prolonged-release Tacrolimus After Conversion From Immediate-release Tacrolimus in Kidney Transplantation: A Retrospective Analysis of Long-term Outcomes From the ADMIRAD Study
5. Recurrence and Outcome of Anti−Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation
6. Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial
7. Diagnostic yield of 18F-FDG PET/CT imaging and urinary CXCL9/creatinine levels in kidney allograft subclinical rejection
8. La tomographie par émission de positons au 18F-FDG en pathologie rénale non oncologique : indications actuelles et perspectives
9. International comparison and time trends of first kidney transplant recipient characteristics across Europe: an ERA Registry study.
10. Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation
11. International comparison and time trends of first kidney transplant recipient characteristics across Europe: an ERA Registry study
12. The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes
13. Observer variability in the assessment of renal 18F-FDG uptake in kidney transplant recipients
14. Mesenchymal Stromal Cells in Solid Organ Transplantation
15. The Effect of Elective Ligation of the Arteriovenous Fistula on Cardiac and Renal Functions in Kidney Transplant Recipients
16. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial
17. “Acute kidney dysfunction with no rejection” is associated with poor renal outcomes at 2 years post kidney transplantation
18. Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study
19. The closure of arteriovenous fistula in kidney transplant recipients is associated with an acceleration of kidney function decline
20. The prospective screening for SARS-CoV-2 S1/S2 antibodies delineates the factual incidence of COVID-19 and shows a sustained serological response post COVID-19 in kidney transplant recipients
21. Age-adapted percentiles of measured glomerular filtration in healthy individuals : extrapolation to living kidney donors over 65 years.
22. The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation
23. The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation
24. Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis
25. The prospective screening for SARS-CoV-2 S1/S2 antibodies delineates the factual incidence of COVID-19 and shows a sustained serological response post COVID-19 in kidney transplant recipients.
26. MO542: Bone Mineral Density, Bone Micro-Architecture Evolution After Kidney Transplantation: A Prospective Cohort Study
27. The ahus registry results in Belgium
28. The Case | An unusual cause of renal vascular thrombi after kidney transplantation
29. Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2
30. Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years
31. The prospective screening for SARS-CoV-2 S1/S2 antibodies delineates the factual incidence of COVID-19 and shows a sustained serological response postCOVID-19 in kidney transplant recipients
32. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)
33. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence
34. RECURRENCE AND OUTCOME OF ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS AFTER KIDNEY TRANSPLANTATION: A BELGIAN MULTICENTER STUDY
35. Recurrence and Outcome of Anti-Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation.
36. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?
37. Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion
38. FC 121THE UPTAKE OF PET RADIOTRACER 18 F-FLUORODEOXYGLUCOSE BY THE RENAL ALLOGRAFT SIGNIFICANTLY CORRELATES WITH THE ACUTE BANFF SCORES OF CORTEX INFLAMMATION
39. FC 055PERCENTILES OF NORMAL MEASURED GLOMERULAR FILTRATION RATE BASED ON DATA FROM LIVING KIDNEY DONORS
40. MO939RECURRENCE AND OUTCOME OF ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS AFTER KIDNEY TRANSPLANTATION: A BELGIAN MULTICENTER STUDY
41. [18F]FDG PET/CT Imaging Disproves Renal Allograft Acute Rejection in Kidney Transplant Recipients with Acute Kidney Dysfunction: A Validation Cohort
42. Repeated kidney re-transplantation-the Eurotransplant experience: a retrospective multicenter outcome analysis
43. Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial.
44. Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial
45. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study
46. Kidney donation after circulatory death in a country with a high number of brain dead donors: 10-year experience in Belgium
47. Results of kidney transplantation from controlled donors after cardio-circulatory death: a single center experience
48. Outcome of the living kidney donor
49. BELGIAN EXPERIENCE OF DCD KIDNEY TRANSPLANTATION: O-157
50. Re: The role of FDG PET in detecting rejection after liver transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.